Sheet 6 Flashcards

1
Q

The basal ganglia (site 4) have several functions, such as:

A

Controlling and regulating

movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Parkinson’s disease (PD)?

A

A neurodegenerative disease marked by a hypokinetic movement disorder that is caused by loss of dopaminergic neurons from the substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

All neurodegenerative diseases are characterized by:

A

Accumulation of proteins inside the CNS (but they differ in the type of protein and site of deposition) = becomes toxic to the neurons = their death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the most common neurodegenerative disease?

A

Alzheimer’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the second most common neurodegenerative disease?

A

Parkinson’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Parkinsonsim?

A

A clinical syndrome: tremor, rigidity, bradykinesia, and instability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the definition of Parkinsonism?

A

Any damage of dopaminergic neurons, which project from the substantia nigra to the striatum (control of motor activity).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens to the substantia nigra in Parkinson’s in regards to pigmentation?

A

It’s original brown color loses its pigmentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Parkinsonism can be induced by:

A

Drugs such as dopamine antagonists or toxins that selectively injure dopaminergic neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the pathogenesis of PD?

A

1) Protein accumulation and aggregation, mitochondrial abnormalities, and neuronal loss in the substantia nigra and elsewhere in the brain.
2) Abnormal protein and organelle clearance due to defects in autophagy and lysosomal degradation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the diagnostic feature of PD?

A

Lewy body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are Lewy bodies?

A

Neuronal inclusions inside the cytoplasm containing α-synuclein, a protein involved in synaptic transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most PD cases are __, but some are __.

A

Sporadic; autosomal dominant (mutation of α-synuclein gene)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What color do Lewy bodies in a neuron from the substantia nigra stain?

A

Pink

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do Lewy bodies look like histologically?

A

Amorphous homogeneous rounded to oval inclusions in the cytoplasm of neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the morphology of PD?

A

1) Pallor of the substantia nigra and locus ceruleus. (due to loss of pigmentation)
2) Loss of the pigmented neurons in these regions.
3) Gliosis
4) Lewy bodies in neurons (single or multiple, cytoplasmic, eosinophilic, round to elongated
inclusions)
5) Lewy neurites
6) Immunohistochemical staining for α-synuclein (for subtle lewy bodies).
7) With progression changes can appear in: medulla, pons, amygdala, and the cerebral cortex (+Lewy body dementia LBD).
8) Lewy body dementia LBD

17
Q

What are Lewy neurites?

A

Dystrophic neurites that also contain aggregated α-synuclein

18
Q

What do α-synuclein look like under the microscope?

A

Appear brown in color

19
Q

What is Lewy body dementia LBD?

A

With involvement of the cerebral cortex, there is typically dementia (loss of cognitive features, memory disturbances, behavioral changes) in addition to the movement disorder.

20
Q

True or false:
Parkinson’s itself does not affect the cognitive features without progression to
the cerebral cortex.

A

True

21
Q

The progression of PD is:

A

1) Gradual (over 10 to 15 years (slow downhill))
2) Eventually produces severe motor slowing or near immobility
3) Death due to aspiration pneumonia or trauma from falls caused by postural instability (gait disorder).

22
Q

What is the treatment of PD?

A

1) Initially responds to L-DOPA, but this treatment does not slow disease progression or reverse morphologic findings.(doesn’t affect protein aggregation or neuron loss).
2) Deep brain stimulation

23
Q

Does L-DOPA help in the long-run?

A

No; over time, L-DOPA becomes less effective (causes dependence).

24
Q

What are the symptoms of PD?

A

1) Tremor
2) Slowed movement (bradykinesia)
3) Rigid muscles
4) Impaired posture and balance
5) Loss of automatic movements
6) Speech changes
7) Writing changes
8) Diminished facial expressions (Masked faces)
9) Stooped posture and balance problems
10) Slow voluntary movement
11) Festinating gait= progressively shortened accelerated steps.

25
Q

Describe the bradykinesia (slowed movement) of PD.

A

1) Steps may become shorter
2) Difficult to get out of a chair
3) Drag their feet as they try to walk (Shuffling, festinating gate)

26
Q

Describe the tremors of PD.

A

Involuntary shaking, usually at rest and disappears with movement. Begins in a limb, often in the hands or fingers. Patients might rub their thumb and forefinger back-and-forth ( pill-rolling tremor.)

27
Q

Describe the loss of automatic movements of PD.

A

Decreased ability to perform unconscious movements, including blinking, smiling (masked face), or swinging arms during walking

28
Q

Describe the speech changes of PD.

A

Patients might speak softly, quickly, slur, or hesitate before talking

29
Q

What is Huntington’s disease characterized by?

A

1) Hypermotility or mobility

2) Choreiform dancing movements of the whole body (from the head to the limbs and trunk) called chorea

30
Q

What is the cause of Huntington’s?

A

Degeneration of the striatum (caudate and putamen) as a result of
protein accumulation.

31
Q

Huntington’s mode of inheritance is:

A

Autosomal dominant (NOT sporadic)

32
Q

What is the progression of Huntington’s?

A

Gradual, death after an average of 15 years

33
Q

Do cognitive symptoms occur in Huntington’s?

A

Yes, early on (forgetfulness and thought and affective disorders, severe
dementia).

34
Q

What is the pathogenesis of Huntington’s?

A

CAG trinucleotides repeat expansions in huntingtin protein gene located on 4p16.3 (Polyglutamine) (hundreds of repeats)

35
Q

What do larger numbers of repeats result in?

A

Earlier-onset disease

36
Q

What happens genetically in Huntington’s?

A

Mutant protein is subject to proteolysis = fragments form large intranuclear aggregates (not in the cytoplasm) = toxic = loss of neurons

37
Q

What is the age of onset in Huntington’s and what does it depend on?

A

40-50 years; related to the length of CAG repeats (more repeats = earlier age of onset)

38
Q

What is the morphology of Huntington’s?

A

1) Atrophic brain
2) Striking atrophy of the caudate nucleus and the putamen
3) Atrophy of globus pallidus
4) Dilated lateral and third ventricles secondarily (like Alzheimer’s but at small age)
5) Severe loss of neurons from affected regions of the striatum + gliosis
6) Spiny neurons that release γ-aminobutyric acid (GABA), enkephalin, dynorphin, and substance P are especially sensitive, disappearing early.
7) Intranuclear inclusions (aggregates of ubiquitinated huntingtin protein)